Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Ovarian Hyperstimulation Syndrome

bromocriptine has been researched along with Ovarian Hyperstimulation Syndrome in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Bu, X; Jia, C; Liu, Y; Ma, Y; Wang, S; Zhang, Q1
Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD1
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G1
Beketić-Orešković, L; Ježek, D; Kasum, M; Orešković, S; Pekez, M; Stanić, P; Vrčić, H1
Hart, RJ; Mourad, S; Tang, H; Zhai, SD1
Haidbauer, R; Murtinger, M; Spitzer, D; Wogatzky, J; Zech, MH; Zech, NH1
Wiwanitkit, V2
Baracat, EC; Beltrame, AL; Motta, EL; Serafini, P; Soares Júnior, JM1
Ando, H; Fukugaki, H; Matsuzawa, K; Mizutani, S; Murata, Y; Nagasaka, T; Saito, K; Takahashi, I1

Reviews

4 review(s) available for bromocriptine and Ovarian Hyperstimulation Syndrome

ArticleYear
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2021, 04-14, Volume: 4

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic

2021
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
    Acta clinica Croatica, 2017, Volume: 56, Issue:1

    Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate

2017
Dopamine agonists in prevention of ovarian hyperstimulation syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:12

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction

2014
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2016, 11-30, Volume: 11

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted

2016

Trials

1 trial(s) available for bromocriptine and Ovarian Hyperstimulation Syndrome

ArticleYear
The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:3

    Topics: Adult; Brazil; Bromocriptine; Dopamine Agonists; Double-Blind Method; Female; Fertilization in Vitro; Glomerular Filtration Rate; Humans; Incidence; Infertility, Female; Kidney; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Patient Dropouts; Pilot Projects; Risk; Severity of Illness Index; Sodium; Vascular Endothelial Growth Factor A

2013

Other Studies

5 other study(ies) available for bromocriptine and Ovarian Hyperstimulation Syndrome

ArticleYear
Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 159, Issue:3

    Topics: Bromocriptine; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Retrospective Studies; Starch

2022
Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
    Fertility and sterility, 2011, Jun-30, Volume: 95, Issue:8

    Topics: Adult; Austria; Bromocriptine; Dopamine Agonists; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult

2011
Prevention of ovarian hyperstimulation syndrome.
    Fertility and sterility, 2011, Jun-30, Volume: 95, Issue:8

    Topics: Bromocriptine; Dopamine Agonists; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Risk Factors; Severity of Illness Index; Treatment Outcome

2011
Ovarian hyperstimulation syndrome.
    Singapore medical journal, 2011, Volume: 52, Issue:5

    Topics: Adult; Bromocriptine; Female; Gonadotropins; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Research Design; Retrospective Studies

2011
Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:5

    Topics: Adenoma; Adult; Anovulation; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Humans; Infertility, Female; Magnetic Resonance Imaging; Ovarian Hyperstimulation Syndrome; Pituitary Neoplasms; Pregnancy; Prolactin; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, X-Ray Computed

2003